Skip to content
‹ Back to IndustriesSciences

The Great Texas Freeze of 2021 is Still Having an Impact on Trees. Here’s The Science Behind It.

The Great Texas Freeze The Great Texas Freeze of 2021 had varied negative consequences on the region, from actual fatalities, to damage to infrastructure and utilities. It’s not only still being felt, but often missed in tackling the lingering effects of weather anomalies: The impact on Texas’ trees. For example, East Texas pine trees face…

This story was produced through MarketScale. See how Sciences teams put it to work with Executive Thought Leadership.

By Sciences · · BarkBudding SeasonForest ManagementIps Engraver Beetles
Share

Key takeaways

01

The Great Texas Freeze The Great Texas Freeze of 2021 had varied negative consequences on the region, from actual fatalities, to damage to infrastructure and utilities.

02

It’s not only still being felt, but often missed in tackling the lingering effects of weather anomalies: The impact on Texas’ trees.

03

For example, East Texas pine trees face…

Free workspace

Turn your Sciences expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

The Great Texas Freeze

The Great Texas Freeze of 2021 had varied negative consequences on the region, from actual fatalities, to damage to infrastructure and utilities. It’s not only still being felt, but often missed in tackling the lingering effects of weather anomalies: The impact on Texas’ trees. For example, East Texas pine trees face a lingering threat from the Great Texas Freeze of 2021 in the form of Ips engraver beetles. The severely stressed trees, weakened by the freeze, are now vulnerable to these beetles that attack both healthy and stressed pines.

It’s important to recognize that trees are influenced by genetic predispositions and regional differences. This helps us better understand the complex interplay between environmental factors and tree health. The damage from the freeze on trees varied among tree species and individual trees, with some being more susceptible to harm due to breaking dormancy early, and trees from different regions, such as North Carolina and Louisiana, can exhibit unique responses to the same stressors. Professionals at the Treenewal Team, including VP of Operations Wesley Rivers, Southern Botanical Pro David Brantley, and Cleanscapes Pro James Theiss, delve deep into the impacts of the recent freeze on trees, touching on genetic predispositions, regional differences, and the need for proper care.

Treenewal Team’s Thoughts:

Wesley Rivers

“But the freeze was devastating to a lot of them. A lot of them looked like nothing happened, and a lot of them got completely killed. And I think the variability there is due to genetic differences. Trees that were breaking dormancy early were absorbing water. Water crystallizes and freezes inside the vascular tissue and ruptures vessels and breaks cell walls. This just devastates the interior of the plant. So, some trees that just were genetically predisposed to be early got really hurt. The timing of the freeze was a big problem because it was late. By mid-February, we’re normally warming up around here; trees had been exposed to 70-plus-degree weather the week before. The days are getting longer. All these things are triggering these trees to start getting active.” – Wesley Rivers, VP of Operations, TreeNewal

David Brantley

“There are live oak trees that spanned from Big Bend all the way up through the United States, and each genetic in that seed, in that tree, has a different time when it breaks bud, has a different way it responds to things like that. So if we’re getting trees from North Carolina, it’s a different tree than you’re getting from Louisiana even though it is a live oak…” – David Brantley, Southern Botanical, TreeNewal

James Theiss

“He’s saying about the freeze damage. You don’t want to strap the bark on, we’ve seen that…. Bark that’s broken and separating, it’s going to fall off. A lot of is popping off right now in trees that people didn’t even know what happened. And the thing around that, remember that trees make their own root soil. So just like Wes was talking, the ones in residential areas are not getting any leaf litter. That leaf litter is supposed to be under the tree. It degrades to go back into the soil, and feeds the tree. But we clean all of that up. We don’t give the trees any substance, they just have to use what’s available in the soil that we feed them.” – James Theiss, Cleanscapes, TreeNewal

Article written by Azam Saghir.

Your experts belong here

Every story in MarketScale Sciences starts with a company putting its lab directors, applications scientists, and field specialists on the record. Buyers are already reading this topic. The only question is whose experts they find.

Lab and research buyers verify before they trial, and your scientists give them something credible to verify against.

Book DemoSee how it works15 minutes, straight to a calendar.

About the author

S
Sciences
B2B Weekly

The week in Sciences, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Sciences: are you visible to AI?

Before they reach out, Sciences buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Sciences expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your lab directors, applications scientists, and field specialists into the articles, video, and social content Sciences buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Sciences Insights

AI shows up in all five tracks at ISPE's 2026 Annual Meeting

AI shows up in all five tracks at ISPE's 2026 Annual Meeting

ISPE's 2026 Annual Meeting and Expo in Washington, DC organizes its program around five tracks running from discovery to governance, with international program committee chair Connie Langer of Pfizer Global Supply and executive chair Jose Caraballo of JCO Global Advisory LLC explaining why AI appears across every track rather than in a standalone one. Deloitte's December 2025 survey of 280 executives frames the mood the program is built for.

  • 01ISPE's 2026 Annual Meeting has no dedicated AI track; program chairs expect AI presentations across all five tracks, from discovery to governance.
  • 02Deloitte's December 2025 survey of 280 biopharma and medtech C-suite executives found more than 75% confident in their own financial outlook but only 41% optimistic about the global economy, the mood the program is built for.
  • 03A staffing firm reports life sciences job openings falling even as digital fluency becomes a required skill, so the upskilling burden lands on the people already employed, which is where the mandatory, university-partnered AI training Connie Langer describes at her company sits.

Sep 30, 2026

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site fits the tumor model to the therapy, not the reverse

Crown Bioscience's San Diego site designs preclinical tumor models to match specific therapies and delivery routes, rather than forcing treatments into standard study designs. It combines custom surgical procedures, cell line-derived xenografts, patient-derived xenografts (including post-treatment models), and biomarker capabilities to generate translational data that can help sponsors decide whether to advance a program.

  • 01Orthotopic brain tumor implantation with tagged models enables tracking of tumor growth in the organ where it naturally occurs, supporting clinically relevant assessment of therapies delivered in that setting.
  • 02Patient-derived xenografts developed from tumors after prior treatment may better reflect progressed disease, helping teams study therapies aimed at patients whose cancer has advanced after earlier treatment.
  • 03Combining biomarker analysis of preclinical model samples with clinical sample testing at one site could make it easier to connect what is measured in animals with what is later measured in patients.

Sep 30, 2026

Clinical data harmonization is the bottleneck for life sciences AI

Clinical data harmonization is the bottleneck for life sciences AI

Life sciences companies moving AI from experimentation to scale keep running into messy trial data. One study can draw on EDC, health records, eCOA tools, wearables and imaging, and data teams at pharma SMEs often spend up to 80% of their time wrangling it. Commentators point to lakehouse architectures and data-cleansing AI agents, though the agents are still at proof of concept.

  • 01Treat automation gains as proof-of-concept for now; evaluate AI/harmonization choices based on data readiness, governance, and whether the architecture supports traceability and regulatory needs.

Sep 26, 2026

Explore More Sciences Insights

Read more expert perspectives from across Sciences.

Browse Sciences Hub

About the Expert

S
Sciences

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Sciences and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512